Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 11932
TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661993(US11944616, Compound 31)
Affinity DataIC50: 270nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM50000663((5S,10S)-(+)-5-methyl-10,11-dihydro-5Hdibenzo[a,d]...)
Affinity DataIC50: 290nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661992(US11944616, Compound 27)
Affinity DataIC50: 360nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661989(US11944616, Compound 5)
Affinity DataIC50: 400nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661991(US11944616, Compound 26)
Affinity DataIC50: 400nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661987(US11944616, Compound 3)
Affinity DataIC50: 500nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661986(US11944616, Compound 2)
Affinity DataIC50: 570nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661985(US11944616, Compound 1)
Affinity DataIC50: 650nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661988(US11944616, Compound 4)
Affinity DataIC50: 820nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 1(Rat)
Institut National De La Sante Et De La Recherche Medicale (Inserm

US Patent
LigandPNGBDBM661990(US11944616, Compound 6)
Affinity DataIC50: 1.10E+3nMAssay Description:In Vitro Activity: Evaluation of NMDAR Blocking Activity Using Patch-ClampPrevious studies have shown that the NMDAR exists in the peripheral vascula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2024
Entry Details
Go to US Patent